Literature DB >> 16177301

Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Martinha S Oliveira1, Alexandra G Fraga, Egídio Torrado, António G Castro, João P Pereira, Adhemar Longatto Filho, Fernanda Milanezi, Fernando C Schmitt, Wayne M Meyers, Françoise Portaels, Manuel T Silva, Jorge Pedrosa.   

Abstract

Buruli ulcer (BU) is a devastating, necrotizing, tropical skin disease caused by infections with Mycobacterium ulcerans. In contrast to other mycobacterioses, BU has been associated with minimal or absent inflammation. However, here we show that in the mouse M. ulcerans induces persistent inflammatory responses with virulence-dependent patterns. Mycolactone-positive, cytotoxic strains are virulent for mice and multiply progressively, inducing both early and persistent acute inflammatory responses. The cytotoxicity of these strains leads to progressive destruction of the inflammatory infiltrates by postapoptotic secondary necrosis, generating necrotic acellular areas with extracellular bacilli released by the lysis of infected phagocytes. The necrotic areas, always surrounded by acute inflammatory infiltrates, expand through the progressive invasion of healthy tissues around the initial necrotic lesions by bacteria and by newly recruited acute inflammatory cells. Our observations show that the lack of inflammatory infiltrates in the extensive areas of necrosis seen in advanced infections results from the destruction of continuously produced inflammatory infiltrates and not from M. ulcerans-induced local or systemic immunosuppression. Whether this is the mechanism behind the predominance of minimal or absent inflammatory responses in BU biopsies remains to be elucidated.

Entities:  

Mesh:

Year:  2005        PMID: 16177301      PMCID: PMC1230890          DOI: 10.1128/IAI.73.10.6299-6310.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

Review 1.  Phagocytosis of apoptotic cells and the resolution of inflammation.

Authors:  Paola Maderna; Catherine Godson
Journal:  Biochim Biophys Acta       Date:  2003-11-20

2.  Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.

Authors:  K M George; D Chatterjee; G Gunawardana; D Welty; J Hayman; R Lee; P L Small
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

3.  The histopathologic spectrum in Mycobacterium marinum infection.

Authors:  W D Travis; L B Travis; G D Roberts; D W Su; L W Weiland
Journal:  Arch Pathol Lab Med       Date:  1985-12       Impact factor: 5.534

Review 4.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum.

Authors:  K Chemlal; G Huys; P A Fonteyne; V Vincent; A G Lopez; L Rigouts; J Swings; W M Meyers; F Portaels
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

7.  BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda.

Authors: 
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

8.  Intracellular growth and cytotoxicity of Mycobacterium haemophilum in a human epithelial cell line (Hec-1-B).

Authors:  L J Fischer; F D Quinn; E H White; C H King
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Response in the hindfoot pad and popliteal lymph node of C57BL mice to infection with Mycobacterium marinum.

Authors:  N Mor; I Lutsky; L Levy
Journal:  Isr J Med Sci       Date:  1981-04

10.  Host and bacterial factors control the Mycobacterium avium-induced chronic peritoneal granulocytosis in mice.

Authors:  R Appelberg; J M Pedrosa; M T Silva
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more
  47 in total

1.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

3.  Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.

Authors:  Masamichi Goto; Kazue Nakanaga; Thida Aung; Tomofumi Hamada; Norishige Yamada; Mitsuharu Nomoto; Shinichi Kitajima; Norihisa Ishii; Suguru Yonezawa; Hajime Saito
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 4.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

5.  Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.

Authors:  J W C Alffenaar; W A Nienhuis; F de Velde; A T Zuur; A M A Wessels; D Almeida; J Grosset; O Adjei; D R A Uges; T S van der Werf
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

6.  Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

Authors:  Joseph Tuffour; Evelyn Owusu-Mireku; Marie-Therese Ruf; Samuel Aboagye; Grace Kpeli; Victor Akuoku; Janet Pereko; Albert Paintsil; Kofi Bonney; William Ampofo; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

Review 7.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

8.  Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.

Authors:  R Hurtado Ortiz; D Aguilar Leon; H Orozco Estevez; A Martin; J Luna Herrera; L Flores Romo; F Portaels; R Hernandez Pando
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  Virulence attenuation of Candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection.

Authors:  Paula Sampaio; Marlene Santos; Alexandra Correia; Fábio E Amaral; Julio Chavéz-Galarza; Sofia Costa-de-Oliveira; António G Castro; Jorge Pedrosa; Célia Pais
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  The local immune response in ulcerative lesions of Buruli disease.

Authors:  A E Kiszewski; E Becerril; L D Aguilar; I T A Kader; W Myers; F Portaels; R Hernàndez Pando
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.